SYSTEMATIC REVIEW article

Front. Digit. Health

Sec. Human Factors and Digital Health

Volume 7 - 2025 | doi: 10.3389/fdgth.2025.1584764

This article is part of the Research TopicDigital mindfulness in primary care: Enhancing health through technologyView all articles

Effectiveness of Mobile Health (mHealth) in Symptom Management of Prostate Cancer Patients: A Systematic Review and Meta-Analysis

Provisionally accepted
Haishan  ChenHaishan Chen*Hua  HeHua HeHaihang  LinHaihang LinYuan  ZhangYuan ZhangNu  LiNu LiYamei  LiYamei Li*
  • Department of Urology, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China

The final, formatted version of the article will be published soon.

Background Mobile health (mHealth) is an accessible strategy to deliver health information and becoming increasingly popular as a form of follow-up among medical staff. However, the effects of mobile health on the physical and mental health outcomes of prostate cancer patients after discharge from hospital remain unclear. This meta-analysis evaluated the current evidence regarding the effects of mHealth interventions on prostate cancer patients outcomes.Methods Four databases (PubMed, Cochrane Central electronic database, EMBASE and Web of science) were searched from inception to November 8, 2024 for randomized controlled trials (RCTs) comparing the effects of mobile health versus usual care on prostate cancer patients outcomes.Pooled outcome measures were determined using random-effects models.Eleven RCTs including 1,368 patients met the criteria for inclusion in this meta-analysis.Meta-analyses revealed a significant effect of mHealth interventions on long-term bowel function outcomes (standard mean difference [SMD]=0.19, 95%CI=0.

Keywords: Prostate cancer1, Mobile Health (mHealth)2, Symptom management3, Long-term effects4, Short-term effects5, meta-analysis6

Received: 02 Mar 2025; Accepted: 11 Apr 2025.

Copyright: © 2025 Chen, He, Lin, Zhang, Li and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Haishan Chen, Department of Urology, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China
Yamei Li, Department of Urology, Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more